Dr. Daniel Harki Mentioned in News Story

Jan. 19, 2017

Dr. Daniel Harki is mentioned in the Business Wire story, "Accelerator Corporation Announces $7M Series A Investment in ApoGen Biotechnologies to Develop a New Class of Drugs Targeting Resistance to Cancer Therapy."